Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR-Mutated Non-Small Cell Lung Cancer
Patritumab Deruxtecan (HER3-DXd) 在 EGFR 抑制剂耐药、EGFR 突变型非小细胞肺癌中的疗效和安全性
期刊:Cancer Discovery
影响因子:33.3
doi:10.1158/2159-8290.CD-21-0715
Jänne, Pasi A; Baik, Christina; Su, Wu-Chou; Johnson, Melissa L; Hayashi, Hidetoshi; Nishio, Makoto; Kim, Dong-Wan; Koczywas, Marianna; Gold, Kathryn A; Steuer, Conor E; Murakami, Haruyasu; Yang, James Chih-Hsin; Kim, Sang-We; Vigliotti, Michele; Shi, Rong; Qi, Zhenhao; Qiu, Yang; Zhao, Lihui; Sternberg, David; Yu, Channing; Yu, Helena A